Results 211 to 220 of about 1,853,445 (346)
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li +12 more
wiley +1 more source
Symbolic Analysis of the Quality of Texts Translated into a Language Preserving Vowel Harmony. [PDF]
Hayata K.
europepmc +1 more source
Zur Constitution der Ricinölsäure und Ricinstearolsäure [PDF]
A. G. Goldsobel
openalex +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi +12 more
wiley +1 more source
Pain Treatment in Primary Care Through Eight Constitution Medicine: A Retrospective Real-World Study from South Korea. [PDF]
Cho N +7 more
europepmc +1 more source
Ueber die Constitution der Tetrinsäure (α‐Methyl‐tetronsäure) [PDF]
Ludwig Wolff
openalex +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza +3 more
wiley +1 more source
Exploring the mediating factors linking adverse childhood experiences to traditional Chinese quality of life among older adults: a multi-factorial analysis. [PDF]
Sun M +11 more
europepmc +1 more source
Ueber die Constitution der Chrysamminsäure und über das Chrysazin [PDF]
C. Liebérmann, F. Giesel
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source

